FRMD4A and Alzheimer disease: A less known genetic risk factor for AD, FRMD4A, has been shown to affect TAU secretion, and is thought to modulate TAU release as well as cell-to-cell transmission in AD via the FRMD4A-cytohesin-Arf6 presynaptic vesicle pathway [131].